M. DAVID MACFARLANE, PH.D. - Corporate Board Profile

TITAN PHARMACEUTICALS INC

Filing Date	Source Excerpt
2002-07-15	Dr. MacFarlane served as Vice President and Responsible Head of Regulatory Affairs of Genentech, Inc.
2003-07-14	Dr. MacFarlane served as Vice President and Responsible Head of Regulatory Affairs of Genentech Inc.
2004-08-11	Dr. MacFarlane served as Vice President and Responsible Head of Regulatory Affairs of Genentech, Inc.
2005-07-12	From 1989 until his retirement in August 1999, Dr. MacFarlane served as Vice President and Responsible Head of Regulatory Affairs of Genentech, Inc.
2006-08-10	Dr. MacFarlane served as Vice President and Responsible Head of Regulatory Affairs of Genentech, Inc.
2007-08-15	Dr. MacFarlane served as Vice President and Responsible Head of Regulatory Affairs of Genentech, Inc.
2008-04-03	From 1989 until his retirement in August 1999, Dr. MacFarlane served as Vice President and Responsible Head of Regulatory Affairs of Genentech, Inc.
2015-07-20	Based on Dr. MacFarlanes management experience in the pharmaceutical industry, particularly in the area of clinical and regulatory affairs, our Board believes that Dr. MacFarlane has the appropriate set of skills to serve as a member of the Board.
2016-06-29	Based on Dr. MacFarlanes management experience in the pharmaceutical industry, particularly in the area of clinical and regulatory affairs, our Board believes that Dr. MacFarlane has the appropriate set of skills to serve as a member of the Board.
2017-06-26	Dr. MacFarlane served as Vice President and Responsible Head of Regulatory Affairs of Genentech, Inc. from 1989 until his retirement in August 1999. Prior to joining Genentech, Inc., he served in various positions with Glaxo Inc., last as Vice President of Regulatory Affairs. Based on Dr. MacFarlane’s management experience in the pharmaceutical industry, particularly in the area of clinical and regulatory affairs, our Board believes that Dr. MacFarlane has the appropriate set of skills to serve as a member of the Board.
2018-07-02	M. David MacFarlane, Ph.D. served as Vice President and Responsible Head of Regulatory Affairs of Genentech, Inc. from 1989 until his retirement in August 1999. Based on Dr. MacFarlane’s management experience in the pharmaceutical industry, particularly in the area of clinical and regulatory affairs, our Board believes that Dr. MacFarlane has the appropriate set of skills to serve as a member of the Board.
2019-11-20	Based on Dr. MacFarlane’s management experience in the pharmaceutical industry, particularly in the area of clinical and regulatory affairs, our Board believes that Dr. MacFarlane has the appropriate set of skills to serve as a member of the Board.
2020-01-31	M. David MacFarlane, Ph.D.(7) - Includes (i) 8,944 shares issuable upon exercise of outstanding options and (ii) 13,334 shares issuable upon exercise of outstanding warrants.
2020-05-22	M. David MacFarlane, Ph.D.(6) - Includes (i) 8,944 shares issuable upon exercise of outstanding options and (ii) 13,334 shares issuable upon exercise of outstanding warrants.
2020-11-02	M. David MacFarlane, Ph.D.
2020-11-25	Based on Dr. MacFarlane’s management experience in the pharmaceutical industry, particularly in the area of clinical and regulatory affairs, our Board believes that Dr. MacFarlane has the appropriate set of skills to serve as a member of the Board.
2021-11-05	Dr. MacFarlane’s management experience in the pharmaceutical industry, particularly in the area of clinical and regulatory affairs, our Board believes that Dr. MacFarlane has the appropriate set of skills to serve as a member of the Board.
2023-05-19	M. David MacFarlane, Ph.D. served as Vice President and Responsible Head of Regulatory Affairs of Genentech, Inc. from 1989 until his retirement in August 1999. Prior to joining Genentech, Inc., he served in various positions with Glaxo Inc., last as Vice President of Regulatory Affairs.